Lupus is notorious for its unpredictable symptoms, which can vary significantly from person to person. Some of the most common symptoms include: Fatigue: A feeling of overwhelming tiredness that does ...

The recent passing of singer Selena has shocked fans and friends alike, highlighting the serious impact of lupus, a chronic autoimmune disease. This article explores the implications of lupus, the ...

At ACR 2025, early data of CTA313, a universal CD19/BCMA CAR-T therapy, demonstrate safety and strong responses in refractory ...

Common recommendations are to start HCQ treatment with doses of 200 mg or 400 mg per day. Some formulas suggest a ...

In a 52-week trial of patients with active systemic lupus erythematosus (SLE) receiving standard background therapy, ...

CHICAGO -- People who died with systemic lupus erythematosus (SLE) were far more likely than car crash victims to have severe ...

Although overall mortality rates for patients with lupus have declined since the turn of the century, racial, sex and ...

Objectives To investigate whether systemic lupus erythematosus (SLE) increases the risk of cataract development and to ...

Ajertil, A., Jirari Rim, M’Benga. L.-J.K. and El Quessar, A. (2025) Severe and Rare Cerebrovascular Involvement in Systemic Lupus Erythematosus: Case Report and Literature Review. Open Access Library ...

Recommendation based on TULIP-SC Phase III trial results showing first-in-class Saphnelo reduced disease activity via once-weekly subcutaneous administration AstraZeneca's Saphnelo (anifrolumab) has ...

AstraZeneca has announced that Saphnelo (anifrolumab) has been recommended for approval in the European Union (EU) as a ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab) for the treatment of adult ...